Verition Fund Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
+59,670
| New | +$301K | ﹤0.01% | 2480 |
|
|
2025
Q1 | – | Sell |
-145,873
| Closed | -$1.07M | – | 2938 |
|
|
2024
Q4 | $1.07M | Buy |
145,873
+93,079
| +176% | +$683K | ﹤0.01% | 1492 |
|
|
2024
Q3 | $395K | Buy |
+52,794
| New | +$395K | ﹤0.01% | 1814 |
|
|
2024
Q2 | – | Sell |
-11,714
| Closed | -$119K | – | 2586 |
|
|
2024
Q1 | $119K | Buy |
+11,714
| New | +$119K | ﹤0.01% | 1959 |
|
|
2022
Q4 | – | Sell |
-16,646
| Closed | -$321K | – | 2197 |
|
|
2022
Q3 | $321K | Buy |
+16,646
| New | +$321K | ﹤0.01% | 1690 |
|
|
2022
Q2 | – | Sell |
-14,090
| Closed | -$362K | – | 2422 |
|
|
2022
Q1 | $362K | Buy |
14,090
+5,901
| +72% | +$152K | ﹤0.01% | 1371 |
|
|
2021
Q4 | $343K | Buy |
+8,189
| New | +$343K | ﹤0.01% | 1336 |
|
|
2020
Q3 | – | Sell |
-40,536
| Closed | -$1.66M | – | 1290 |
|
|
2020
Q2 | $1.66M | Buy |
+40,536
| New | +$1.66M | 0.05% | 220 |
|